Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials

INTRODUCTION: Crohn’s disease (CD) and ulcerative colitis (UC) are remitting–relapsing inflammatory diseases often culminating in disease complications and/or need for surgery. Biologic monoclonal antibody drugs (‘Biologics’) are efficacious for both diseases, but there are no systematic assessments...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Horin, Shomron, Zhao, Yue, Guo, Jing, Mao, Ren, Novack, Lena, Sergienko, Ruslan, Zhang, Jian, Kobayashi, Taku, Hibi, Toshifumi, Chowers, Yehuda, Colombel, Jean Frederic, Peyrin-Biroulet, Laurent, Kaplan, Gilaad, Chen, Min-hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352773/
https://www.ncbi.nlm.nih.gov/pubmed/30782731
http://dx.doi.org/10.1136/bmjopen-2018-024222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352773/
https://www.ncbi.nlm.nih.gov/pubmed/30782731
http://dx.doi.org/10.1136/bmjopen-2018-024222

Ejemplares similares